James Essex serves as Executive at CardioGenics Holdings Inc., where they oversee executive responsibilities. Since joining the company, James Essex has executed 2 insider transactions totaling $50.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 5, 2015 involved purchasing 234,302 shares valued at $25.8K.
James Essex currently holds 759,985 shares of CardioGenics Holdings Inc. (CGNH), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Essex has been a net buyer of CGNH stock. They have purchased $50.8K and sold $0 worth of shares.
James Essex's most recent insider trade was on Feb 5, 2015, when they purchased 234,302 shares at $0.11 per share.
Get notified when new Form 4 filings are submitted
| $0.11 |
| Discretionary |